SFM
CANO

Spartan Fund Management’s Cano Health, Inc. CANO Stock Holding History

Spartan Fund Management’s Portfolio CANO Stock Details CANO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-15
Closed -$13K – 455
2022
Q3 		$13K Buy
+15
New +$9.4K ﹤0.01% 319

Other funds holding CANO

JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
OCAM
Owl Creek Asset Management New York $1.21B AUM 169.99% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

Spartan Fund Management's CANO Position: Q4 2022 in Review

Spartan Fund Management sold out of Cano Health, Inc. (CANO) in Q4 2022, closing a stake of 15 shares — an estimated $13K sold.

Spartan Fund Management first reported a position in CANO in Q3 2022 and held it in 1 quarter. The position peaked at $13K in Q3 2022. 186 funds tracked by Wall St. Rank hold CANO as of Q4 2022.

  • Spartan Fund Management reported no remaining Cano Health, Inc. position as of Q4 2022 after selling out during the quarter.
  • Spartan Fund Management sold 15 Cano Health, Inc. shares in Q4 2022, an estimated $13K.
  • Spartan Fund Management first reported a position in Cano Health, Inc. in Q3 2022 and held it in 1 quarter.
  • Spartan Fund Management's Cano Health, Inc. position peaked at $13K in Q3 2022.
  • 186 funds tracked by Wall St. Rank held Cano Health, Inc. as of Q4 2022.

Based on Spartan Fund Management's 13F filing for Q4 2022, filed 24 Jan 2023.